Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab

Clinical Rheumatology

Volumn 34, Issue 7, 2015, Pages 1311-1316

  Scarpioni, Roberto ^a   Rigante, Donato ^b   Cantarini, Luca ^c   Ricardi, Marco ^a   Albertazzi, Vittorio ^a   Melfa, Luigi ^a   Lazzaro, Antonio ^a  

^a GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Amyloidosis; Canakinumab; Interleukin 1; Muckle Wells syndrome

Indexed keywords

C REACTIVE PROTEIN; CANAKINUMAB; COLCHICINE; CREATININE; CRYOPYRIN; CYCLOPHOSPHAMIDE; INTERLEUKIN 1BETA; PREDNISONE; SERUM ALBUMIN; SERUM AMYLOID A; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ABSENTEEISM; ADULT; ANEMIA; CASE REPORT; CAUCASIAN; CHRONIC KIDNEY DISEASE; COLON BIOPSY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEVER; FOLLOW UP; GENETIC ANALYSIS; GLOMERULUS FILTRATION RATE; HEMATURIA; HETEROZYGOTE; HUMAN; HUMAN TISSUE; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; MALE; MIDDLE AGED; MUCKLE WELLS SYNDROME; PRIORITY JOURNAL; PROTEINURIA; QUALITY OF LIFE; RASH; RECTOSCOPY; RECTUM HEMORRHAGE; REVIEW; URINALYSIS; AMYLOIDOSIS; CHEMISTRY; COMPLICATION; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; FAMILY HEALTH; INFLAMMATION; KIDNEY DISEASES; KIDNEY FAILURE; METABOLISM; MUTATION;

ADULT; AMYLOIDOSIS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; FAMILY HEALTH; GLOMERULAR FILTRATION RATE; HETEROZYGOTE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; KIDNEY DISEASES; MALE; MIDDLE AGED; MUTATION; PROTEINURIA; RENAL INSUFFICIENCY; SERUM AMYLOID A PROTEIN;

EID: 84931562957     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2481-2     Document Type: Review

References (22)

1. Cantarini L, Rigante D, Brizi MG, Lucherini OM, Sebastiani GD, Vitale A, Gianneramo V, Galeazzi M (2012) Clinical and biochemical landmarks in systemic autoinflammatory diseases. Ann Med 44:664–673
2. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29:301–305
3. Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, Lachmann HJ, Bybee A, Gaudet R, Woo P, Feighery C, Cotter FE, Thome M, Hitman GA, Tschopp J, McDermott MF (2002) Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46:2445–2452
4. Rigante D (2012) The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev 11:348–356
5. Cantarini L, Lucherini OM, Frediani B, Brizi MG, Bartolomei B, Cimaz R, Galeazzi M, Rigante D (2011) Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes. Int J Immunopathol Pharmacol 24:827–836
6. van der Hilst JC, Drenth JPH, Simon A (2005) Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 5:87–98
7. Kümmerle-Deschner JB, Tyrrell PN, Reess F, Kötter I, Lohse P, Girschick H, Huemer C, Horneff G, Haas JP, Koitschev A, Deuter C, Benseler SM (2010) Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum 62:3783–3791
8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:5–14
9. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356:2361–2371
10. Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD (2012) Updates in cardiac amyloidosis: a review. J Am Heart Assoc 1:e000364
11. Lachmann HJ, Lowe P, Felix SD, Rordorf C, Leslie K, Madhoo S, Wittkowski H, Bek S, Hartmann N, Bosset S, Hawkins PN, Jung T (2009) In vivo regulation of interleukin 1β in patients with cryopyrin associated periodic syndromes. J Exp Med 206:1029–1036
12. Hazenberg BP, van Gameren II, Bijzet J, Jager PL, van Rijswijk MH (2004) Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med 62:121–128
13. Enríquez R, Sirvent AE, Padilla S et al (2013) Nephrotic syndrome and AA amyloidosis revealing adult-onset cryopyrin-associated periodic syndrome. Ren Fail 35:738–741
14. Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349:583–596
15. Zhu X, Liu F, Liu Y, Liu H, Xu X, Peng Y, Sun L, Yuan S (2011) Analysis of clinical and pathological characteristics of 28 cases with renal amyloidosis. Clin Lab 57:947–952
16. Hazenberg BP (2013) Amyloidosis: a clinical overview. Rheum Dis Clin North Am 39:323–345
17. Gertz MA, Kyle RA (1994) Amyloidosis: prognosis and treatment. Semin Arthritis Rheum 24:124–138
18. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358(9275):24–29
19. Yilmaz M, Unsal A, Sokmen M, Kaptanogullari OH, Alkim C, Kabukcuoglu F, Ozagari A, Bor E (2013) Renal involvement in AA amyloidosis: clinical outcomes and survival. Kidney Blood Press Res 37:33–42
20. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G (2005) Cholesterol and Recurrent Events (CARE) Trial Investigators. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68:237–2345
21. Vilaysane A, Chun J, Seamone ME, Wang W, Chin R, Hirota S, Li Y, Clark SA, Tschopp J, Trpkov K, Hemmelgarn BR, Beck PL, Muruve DA (2010) The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 21:1732–1744
22. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, Gitton X, Widmer A, Patel N, Hawkins PN, Canakinumab in CAPS Study Group (2009) Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 360:2416–2425